United States
Trump will unveil a deal with Regeneron to lower drug prices
Apr. 23, 2026
President Donald Trump on Thursday will announce a deal with drugmaker Regeneron to lower the cost of its pharmaceutical products as part of the White House’s signature most-favored-nation drug pricing initiative. The deal involves Regeneron lowering the prices of current and future drugs on Medicaid and selling a cholesterol drug called Praluent for $225 on […]
Continue Reading